The clinical utility of QSM: disease diagnosis, medical management, and surgical planning

Quantitative susceptibility mapping (QSM) is an MR technique that depicts and quantifies magnetic susceptibility sources. Mapping iron, the dominant susceptibility source in the brain, has many important clinical applications. Herein, we review QSM applications in the diagnosis, medical management,...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:NMR in biomedicine 2017-04, Vol.30 (4), p.np-n/a
Hauptverfasser: Eskreis‐Winkler, Sarah, Zhang, Yan, Zhang, Jingwei, Liu, Zhe, Dimov, Alexey, Gupta, Ajay, Wang, Yi
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page n/a
container_issue 4
container_start_page np
container_title NMR in biomedicine
container_volume 30
creator Eskreis‐Winkler, Sarah
Zhang, Yan
Zhang, Jingwei
Liu, Zhe
Dimov, Alexey
Gupta, Ajay
Wang, Yi
description Quantitative susceptibility mapping (QSM) is an MR technique that depicts and quantifies magnetic susceptibility sources. Mapping iron, the dominant susceptibility source in the brain, has many important clinical applications. Herein, we review QSM applications in the diagnosis, medical management, and surgical treatment of disease. To assist in early disease diagnosis, QSM can identify elevated iron levels in the motor cortex of amyotrophic lateral sclerosis patients, in the substantia nigra of Parkinson's disease (PD) patients, in the globus pallidus, putamen, and caudate of Huntington's disease patients, and in the basal ganglia of Wilson's disease patients. Additionally, QSM can distinguish between hemorrhage and calcification, which could prove useful in tumor subclassification, and can measure microbleeds in traumatic brain injury patients. In guiding medical management, QSM can be used to monitor iron chelation therapy in PD patients, to monitor smoldering inflammation of multiple sclerosis (MS) lesions after the blood–brain barrier (BBB) seals, to monitor active inflammation of MS lesions before the BBB seals without using gadolinium, and to monitor hematoma volume in intracerebral hemorrhage. QSM can also guide neurosurgical treatment. Neurosurgeons require accurate depiction of the subthalamic nucleus, a tiny deep gray matter nucleus, prior to inserting deep brain stimulation electrodes into the brains of PD patients. QSM is arguably the best imaging tool for depiction of the subthalamic nucleus. Finally, we discuss future directions, including bone QSM, cardiac QSM, and using QSM to map cerebral metabolic rate of oxygen. Copyright © 2016 John Wiley & Sons, Ltd. Quantitative susceptibility mapping (QSM) is an MR technique that depicts and quantifies magnetic susceptibility sources. Mapping iron, the dominant susceptibility source in the brain, has many important clinical applications. Herein, we review QSM clinical applications in the diagnosis, medical management, and surgical treatment of neurological diseases.
doi_str_mv 10.1002/nbm.3668
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_1881750664</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>1881750664</sourcerecordid><originalsourceid>FETCH-LOGICAL-c4488-e8e9203a4081ffcc78644871dcce05c5d103f2cdcf03deb89c45a5cc920ba1243</originalsourceid><addsrcrecordid>eNqNkV1LwzAUhoMobk7BXyAFb7xY50matKl3OvyCTRHnhVclTdOa0aazaZH9e7MPFQTBqwMnz3nIOS9CxxhGGICcm7QaBWHId1AfQxz7mMZkF_UhZsQPKIceOrB2DgCcBmQf9UgUQ8gI66PX2ZvyZKmNlqL0ulaXul16de49PU8vvExbJaxyVRSmttoOvUpla7QSRhSqUqYdesJknu2aYv2wKIUx2hSHaC8XpVVH2zpALzfXs_GdP3m8vR9fTnxJKee-4iomEAgKHOe5lBEPXT_CmZQKmGQZhiAnMpM5BJlKeSwpE0xKN5QKTGgwQGcb76Kp3ztl26TSVqrSfUPVnU0w5zhiEIb_Qak7CqVx5NDTX-i87hrjFnFUxAmhIY1-hLKprW1UniwaXYlmmWBIVskkLplklYxDT7bCLnU3_Aa_onCAvwE-dKmWf4qSh6vpWvgJNQWV1Q</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1878224647</pqid></control><display><type>article</type><title>The clinical utility of QSM: disease diagnosis, medical management, and surgical planning</title><source>MEDLINE</source><source>Wiley Online Library Journals Frontfile Complete</source><creator>Eskreis‐Winkler, Sarah ; Zhang, Yan ; Zhang, Jingwei ; Liu, Zhe ; Dimov, Alexey ; Gupta, Ajay ; Wang, Yi</creator><creatorcontrib>Eskreis‐Winkler, Sarah ; Zhang, Yan ; Zhang, Jingwei ; Liu, Zhe ; Dimov, Alexey ; Gupta, Ajay ; Wang, Yi</creatorcontrib><description>Quantitative susceptibility mapping (QSM) is an MR technique that depicts and quantifies magnetic susceptibility sources. Mapping iron, the dominant susceptibility source in the brain, has many important clinical applications. Herein, we review QSM applications in the diagnosis, medical management, and surgical treatment of disease. To assist in early disease diagnosis, QSM can identify elevated iron levels in the motor cortex of amyotrophic lateral sclerosis patients, in the substantia nigra of Parkinson's disease (PD) patients, in the globus pallidus, putamen, and caudate of Huntington's disease patients, and in the basal ganglia of Wilson's disease patients. Additionally, QSM can distinguish between hemorrhage and calcification, which could prove useful in tumor subclassification, and can measure microbleeds in traumatic brain injury patients. In guiding medical management, QSM can be used to monitor iron chelation therapy in PD patients, to monitor smoldering inflammation of multiple sclerosis (MS) lesions after the blood–brain barrier (BBB) seals, to monitor active inflammation of MS lesions before the BBB seals without using gadolinium, and to monitor hematoma volume in intracerebral hemorrhage. QSM can also guide neurosurgical treatment. Neurosurgeons require accurate depiction of the subthalamic nucleus, a tiny deep gray matter nucleus, prior to inserting deep brain stimulation electrodes into the brains of PD patients. QSM is arguably the best imaging tool for depiction of the subthalamic nucleus. Finally, we discuss future directions, including bone QSM, cardiac QSM, and using QSM to map cerebral metabolic rate of oxygen. Copyright © 2016 John Wiley &amp; Sons, Ltd. Quantitative susceptibility mapping (QSM) is an MR technique that depicts and quantifies magnetic susceptibility sources. Mapping iron, the dominant susceptibility source in the brain, has many important clinical applications. Herein, we review QSM clinical applications in the diagnosis, medical management, and surgical treatment of neurological diseases.</description><identifier>ISSN: 0952-3480</identifier><identifier>EISSN: 1099-1492</identifier><identifier>DOI: 10.1002/nbm.3668</identifier><identifier>PMID: 27906525</identifier><language>eng</language><publisher>England: Wiley Subscription Services, Inc</publisher><subject>Biomarkers - metabolism ; Brain - diagnostic imaging ; Brain - metabolism ; Brain Diseases - diagnostic imaging ; Brain Diseases - metabolism ; Brain Diseases - surgery ; Diffusion Magnetic Resonance Imaging - methods ; Humans ; Image Enhancement - methods ; iron ; Molecular Imaging - methods ; neurodegenerative diseases ; neurological ; Preoperative Care - methods ; QSM ; quantitative susceptibility mapping ; Surgery, Computer-Assisted - methods ; susceptibility‐weighted imaging</subject><ispartof>NMR in biomedicine, 2017-04, Vol.30 (4), p.np-n/a</ispartof><rights>Copyright © 2016 John Wiley &amp; Sons, Ltd.</rights><rights>Copyright © 2017 John Wiley &amp; Sons, Ltd.</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c4488-e8e9203a4081ffcc78644871dcce05c5d103f2cdcf03deb89c45a5cc920ba1243</citedby><cites>FETCH-LOGICAL-c4488-e8e9203a4081ffcc78644871dcce05c5d103f2cdcf03deb89c45a5cc920ba1243</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://onlinelibrary.wiley.com/doi/pdf/10.1002%2Fnbm.3668$$EPDF$$P50$$Gwiley$$H</linktopdf><linktohtml>$$Uhttps://onlinelibrary.wiley.com/doi/full/10.1002%2Fnbm.3668$$EHTML$$P50$$Gwiley$$H</linktohtml><link.rule.ids>314,777,781,1412,27905,27906,45555,45556</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/27906525$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Eskreis‐Winkler, Sarah</creatorcontrib><creatorcontrib>Zhang, Yan</creatorcontrib><creatorcontrib>Zhang, Jingwei</creatorcontrib><creatorcontrib>Liu, Zhe</creatorcontrib><creatorcontrib>Dimov, Alexey</creatorcontrib><creatorcontrib>Gupta, Ajay</creatorcontrib><creatorcontrib>Wang, Yi</creatorcontrib><title>The clinical utility of QSM: disease diagnosis, medical management, and surgical planning</title><title>NMR in biomedicine</title><addtitle>NMR Biomed</addtitle><description>Quantitative susceptibility mapping (QSM) is an MR technique that depicts and quantifies magnetic susceptibility sources. Mapping iron, the dominant susceptibility source in the brain, has many important clinical applications. Herein, we review QSM applications in the diagnosis, medical management, and surgical treatment of disease. To assist in early disease diagnosis, QSM can identify elevated iron levels in the motor cortex of amyotrophic lateral sclerosis patients, in the substantia nigra of Parkinson's disease (PD) patients, in the globus pallidus, putamen, and caudate of Huntington's disease patients, and in the basal ganglia of Wilson's disease patients. Additionally, QSM can distinguish between hemorrhage and calcification, which could prove useful in tumor subclassification, and can measure microbleeds in traumatic brain injury patients. In guiding medical management, QSM can be used to monitor iron chelation therapy in PD patients, to monitor smoldering inflammation of multiple sclerosis (MS) lesions after the blood–brain barrier (BBB) seals, to monitor active inflammation of MS lesions before the BBB seals without using gadolinium, and to monitor hematoma volume in intracerebral hemorrhage. QSM can also guide neurosurgical treatment. Neurosurgeons require accurate depiction of the subthalamic nucleus, a tiny deep gray matter nucleus, prior to inserting deep brain stimulation electrodes into the brains of PD patients. QSM is arguably the best imaging tool for depiction of the subthalamic nucleus. Finally, we discuss future directions, including bone QSM, cardiac QSM, and using QSM to map cerebral metabolic rate of oxygen. Copyright © 2016 John Wiley &amp; Sons, Ltd. Quantitative susceptibility mapping (QSM) is an MR technique that depicts and quantifies magnetic susceptibility sources. Mapping iron, the dominant susceptibility source in the brain, has many important clinical applications. Herein, we review QSM clinical applications in the diagnosis, medical management, and surgical treatment of neurological diseases.</description><subject>Biomarkers - metabolism</subject><subject>Brain - diagnostic imaging</subject><subject>Brain - metabolism</subject><subject>Brain Diseases - diagnostic imaging</subject><subject>Brain Diseases - metabolism</subject><subject>Brain Diseases - surgery</subject><subject>Diffusion Magnetic Resonance Imaging - methods</subject><subject>Humans</subject><subject>Image Enhancement - methods</subject><subject>iron</subject><subject>Molecular Imaging - methods</subject><subject>neurodegenerative diseases</subject><subject>neurological</subject><subject>Preoperative Care - methods</subject><subject>QSM</subject><subject>quantitative susceptibility mapping</subject><subject>Surgery, Computer-Assisted - methods</subject><subject>susceptibility‐weighted imaging</subject><issn>0952-3480</issn><issn>1099-1492</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2017</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNqNkV1LwzAUhoMobk7BXyAFb7xY50matKl3OvyCTRHnhVclTdOa0aazaZH9e7MPFQTBqwMnz3nIOS9CxxhGGICcm7QaBWHId1AfQxz7mMZkF_UhZsQPKIceOrB2DgCcBmQf9UgUQ8gI66PX2ZvyZKmNlqL0ulaXul16de49PU8vvExbJaxyVRSmttoOvUpla7QSRhSqUqYdesJknu2aYv2wKIUx2hSHaC8XpVVH2zpALzfXs_GdP3m8vR9fTnxJKee-4iomEAgKHOe5lBEPXT_CmZQKmGQZhiAnMpM5BJlKeSwpE0xKN5QKTGgwQGcb76Kp3ztl26TSVqrSfUPVnU0w5zhiEIb_Qak7CqVx5NDTX-i87hrjFnFUxAmhIY1-hLKprW1UniwaXYlmmWBIVskkLplklYxDT7bCLnU3_Aa_onCAvwE-dKmWf4qSh6vpWvgJNQWV1Q</recordid><startdate>201704</startdate><enddate>201704</enddate><creator>Eskreis‐Winkler, Sarah</creator><creator>Zhang, Yan</creator><creator>Zhang, Jingwei</creator><creator>Liu, Zhe</creator><creator>Dimov, Alexey</creator><creator>Gupta, Ajay</creator><creator>Wang, Yi</creator><general>Wiley Subscription Services, Inc</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7QO</scope><scope>8FD</scope><scope>FR3</scope><scope>P64</scope><scope>7X8</scope></search><sort><creationdate>201704</creationdate><title>The clinical utility of QSM: disease diagnosis, medical management, and surgical planning</title><author>Eskreis‐Winkler, Sarah ; Zhang, Yan ; Zhang, Jingwei ; Liu, Zhe ; Dimov, Alexey ; Gupta, Ajay ; Wang, Yi</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c4488-e8e9203a4081ffcc78644871dcce05c5d103f2cdcf03deb89c45a5cc920ba1243</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2017</creationdate><topic>Biomarkers - metabolism</topic><topic>Brain - diagnostic imaging</topic><topic>Brain - metabolism</topic><topic>Brain Diseases - diagnostic imaging</topic><topic>Brain Diseases - metabolism</topic><topic>Brain Diseases - surgery</topic><topic>Diffusion Magnetic Resonance Imaging - methods</topic><topic>Humans</topic><topic>Image Enhancement - methods</topic><topic>iron</topic><topic>Molecular Imaging - methods</topic><topic>neurodegenerative diseases</topic><topic>neurological</topic><topic>Preoperative Care - methods</topic><topic>QSM</topic><topic>quantitative susceptibility mapping</topic><topic>Surgery, Computer-Assisted - methods</topic><topic>susceptibility‐weighted imaging</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Eskreis‐Winkler, Sarah</creatorcontrib><creatorcontrib>Zhang, Yan</creatorcontrib><creatorcontrib>Zhang, Jingwei</creatorcontrib><creatorcontrib>Liu, Zhe</creatorcontrib><creatorcontrib>Dimov, Alexey</creatorcontrib><creatorcontrib>Gupta, Ajay</creatorcontrib><creatorcontrib>Wang, Yi</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Biotechnology Research Abstracts</collection><collection>Technology Research Database</collection><collection>Engineering Research Database</collection><collection>Biotechnology and BioEngineering Abstracts</collection><collection>MEDLINE - Academic</collection><jtitle>NMR in biomedicine</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Eskreis‐Winkler, Sarah</au><au>Zhang, Yan</au><au>Zhang, Jingwei</au><au>Liu, Zhe</au><au>Dimov, Alexey</au><au>Gupta, Ajay</au><au>Wang, Yi</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>The clinical utility of QSM: disease diagnosis, medical management, and surgical planning</atitle><jtitle>NMR in biomedicine</jtitle><addtitle>NMR Biomed</addtitle><date>2017-04</date><risdate>2017</risdate><volume>30</volume><issue>4</issue><spage>np</spage><epage>n/a</epage><pages>np-n/a</pages><issn>0952-3480</issn><eissn>1099-1492</eissn><abstract>Quantitative susceptibility mapping (QSM) is an MR technique that depicts and quantifies magnetic susceptibility sources. Mapping iron, the dominant susceptibility source in the brain, has many important clinical applications. Herein, we review QSM applications in the diagnosis, medical management, and surgical treatment of disease. To assist in early disease diagnosis, QSM can identify elevated iron levels in the motor cortex of amyotrophic lateral sclerosis patients, in the substantia nigra of Parkinson's disease (PD) patients, in the globus pallidus, putamen, and caudate of Huntington's disease patients, and in the basal ganglia of Wilson's disease patients. Additionally, QSM can distinguish between hemorrhage and calcification, which could prove useful in tumor subclassification, and can measure microbleeds in traumatic brain injury patients. In guiding medical management, QSM can be used to monitor iron chelation therapy in PD patients, to monitor smoldering inflammation of multiple sclerosis (MS) lesions after the blood–brain barrier (BBB) seals, to monitor active inflammation of MS lesions before the BBB seals without using gadolinium, and to monitor hematoma volume in intracerebral hemorrhage. QSM can also guide neurosurgical treatment. Neurosurgeons require accurate depiction of the subthalamic nucleus, a tiny deep gray matter nucleus, prior to inserting deep brain stimulation electrodes into the brains of PD patients. QSM is arguably the best imaging tool for depiction of the subthalamic nucleus. Finally, we discuss future directions, including bone QSM, cardiac QSM, and using QSM to map cerebral metabolic rate of oxygen. Copyright © 2016 John Wiley &amp; Sons, Ltd. Quantitative susceptibility mapping (QSM) is an MR technique that depicts and quantifies magnetic susceptibility sources. Mapping iron, the dominant susceptibility source in the brain, has many important clinical applications. Herein, we review QSM clinical applications in the diagnosis, medical management, and surgical treatment of neurological diseases.</abstract><cop>England</cop><pub>Wiley Subscription Services, Inc</pub><pmid>27906525</pmid><doi>10.1002/nbm.3668</doi><tpages>11</tpages></addata></record>
fulltext fulltext
identifier ISSN: 0952-3480
ispartof NMR in biomedicine, 2017-04, Vol.30 (4), p.np-n/a
issn 0952-3480
1099-1492
language eng
recordid cdi_proquest_miscellaneous_1881750664
source MEDLINE; Wiley Online Library Journals Frontfile Complete
subjects Biomarkers - metabolism
Brain - diagnostic imaging
Brain - metabolism
Brain Diseases - diagnostic imaging
Brain Diseases - metabolism
Brain Diseases - surgery
Diffusion Magnetic Resonance Imaging - methods
Humans
Image Enhancement - methods
iron
Molecular Imaging - methods
neurodegenerative diseases
neurological
Preoperative Care - methods
QSM
quantitative susceptibility mapping
Surgery, Computer-Assisted - methods
susceptibility‐weighted imaging
title The clinical utility of QSM: disease diagnosis, medical management, and surgical planning
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-18T14%3A50%3A38IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=The%20clinical%20utility%20of%20QSM:%20disease%20diagnosis,%20medical%20management,%20and%20surgical%20planning&rft.jtitle=NMR%20in%20biomedicine&rft.au=Eskreis%E2%80%90Winkler,%20Sarah&rft.date=2017-04&rft.volume=30&rft.issue=4&rft.spage=np&rft.epage=n/a&rft.pages=np-n/a&rft.issn=0952-3480&rft.eissn=1099-1492&rft_id=info:doi/10.1002/nbm.3668&rft_dat=%3Cproquest_cross%3E1881750664%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=1878224647&rft_id=info:pmid/27906525&rfr_iscdi=true